The Oncidium Foundation Fondation
12.8 FTEThe Oncidium Foundation reported total assets of €60.5m at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jul 2026), with 12.8 full-time equivalents.
The score of The Oncidium Foundation shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
The Oncidium Foundation's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
The Oncidium Foundation's financial analysis
- Solvency98.6%sector median: 48.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of The Oncidium Foundation
7 active director(s) in the register.
and 1 more
The Oncidium Foundation's shareholders and holdings →The Oncidium Foundation's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0838.388.420
- VAT number
- BE0838388420
- Peppol
- Registered · 0208:0838388420 · as of 10 Nov 2026
- Legal form
- Fondation
- Incorporated
- 16 Jun 2011
- Registered office
- 1160 Auderghem
- Size
- Small · 12.8 FTE
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
The Oncidium Foundation (Fondation) has been based in Auderghem since 2011, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of €9.33m and equity of €59.6m; its revenue is not published. With 12.8 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 98.6%, above the median of its sector (48.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to The Oncidium Foundation
Companies in the same business, of comparable size and area, outside its group.
- iTeos Belgium Research and experimental development on natural sciences and engineering Charleroi · balance sheet €46.3m
- Augustine Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €30.9m
- Confo Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €37.8m
- OSIVAX Belgique Research and experimental development on natural sciences and engineering Liège · balance sheet €17.0m
- Devgen Research and experimental development on natural sciences and engineering Ghent · balance sheet €130.9m
- The Akkermansia Company Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €16.9m
- Nanocyl Research and experimental development on natural sciences and engineering Sambreville · balance sheet €13.2m
- Baxter R and D Europe Research and experimental development on natural sciences and engineering Lessines · balance sheet €52.7m
Frequently asked questions about The Oncidium Foundation
What is the revenue of The Oncidium Foundation?
The Oncidium Foundation files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of The Oncidium Foundation?
In Belgium, the VAT number is the company number prefixed with BE: BE0838388420 for The Oncidium Foundation, if the company is VAT-registered. Its company number (CBE) is 0838.388.420.
Where is the registered office of The Oncidium Foundation?
According to the CBE register, the registered office of The Oncidium Foundation is in 1160 Auderghem.
What is the equity of The Oncidium Foundation?
At the close of the 2025 financial year, the equity of The Oncidium Foundation amounts to 59,616,135 €, a solvency of 98.6% of total assets.
How many people work at The Oncidium Foundation?
12.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages The Oncidium Foundation?
The register lists 7 active mandates at The Oncidium Foundation. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of The Oncidium Foundation
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →